New Class Action Lawsuit Accuses Boehringer Ingelheim of Holding Monopoly on Asthma, COPD Inhaler Drugs
May 2, 2024 A new class action lawsuit alleges Boehringer Ingelheim Pharmaceuticals holds an illegal monopoly on two drugs used in inhalation sprays to treat COPD and asthma.